To develop an innovative AI-powered digital twin ecosystem that translates gut microbiome and neuroimmune signals into precision interventions for sleep and mood disorders.
Key Findings:
Gut microbiota significantly influences brain function and sleep regulation, with specific studies supporting this.
Targeted dietary interventions can modify microbial composition and improve neuropsychiatric symptoms, as evidenced by clinical trials.
Dysbiosis is linked to sleep disorders and can be addressed through precision probiotic therapies, with examples from recent research.
Microbial metabolites play a crucial role in regulating sleep architecture and emotional well-being, supported by empirical data.
Interpretation:
The digital twin framework offers a scalable approach to managing complex comorbidities related to sleep and mood disorders, emphasizing the pivotal role of nursing in microbiome-precision medicine and its potential impact on patient outcomes.
Limitations:
Requires rigorous controlled longitudinal trials to establish causality, with potential designs suggested.
Potential challenges in data privacy and ethical considerations in AI applications, with recommendations for best practices.
Conclusion:
This innovative ecosystem positions nursing as a pivotal element in the advancement of microbiome-directed therapies for sleep and mood disorders, highlighting the need for interdisciplinary collaboration.
A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation